EP4125911
Óbísetrapíb til meðhöndlunar á vitglöpum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.3.2022EP published:
24.4.2024EP application number:
22715162.8
EP translation filed:
15.7.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
3.3.2042Expiry date:
3.3.2027Next due date:
31.3.2027
Title in English:
OBICETRAPIB FOR TREATMENT OF DEMENTIASLanguage of the patent:
English
Timeline
Today
4.3.2022EP application
24.4.2024EP Publication
15.7.2024Translation submitted
15.9.2024Registration published
3.3.2027Expires
Owner
Name:
NewAmsterdam Pharma B.V.Address:
(dutch Chamber of Commerce No. 55971946) Gooimeer 2-35, 1411 DC Naarden, NL
Inventor
Name:
DITMARSCH, MarcAddress:
1411 DC Naarden, NL
Name:
KASTELEIN, Johannes Jacob PieterAddress:
1411 DC Naarden, NL
Name:
DAVIDSON, Michael HarveyAddress:
1411 DC Naarden, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202163157586 PDate:
5.3.2021Country:
US
Classification
Categories:
A61K 31/506, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 27.3.2025
Expires: 3.3.2026
Payer: Árnason Faktor ehf.
Number: 5
Paid: 5.3.2026
Expires: 3.3.2027
Payer: Árnason Faktor ehf.